Navigation Links
Studies: Addiction starts with an overcorrection in the brain
Date:7/1/2014

The National Institutes of Health has turned to neuroscientists at the nation's most "Stone Cold Sober" university for help finding ways to treat drug and alcohol addiction.

Brigham Young University professor Scott Steffensen and his collaborators have published three new scientific papers that detail the brain mechanisms involved with addictive substances. And the NIH thinks Steffensen's on the right track, as evidenced by a $2-million grant that will help fund projects in his BYU lab for the next five years.

"Addiction is a brain disease that could be treated like any other disease," Steffensen said. "I wouldn't be as motivated to do this research, or as passionate about the work, if I didn't think a cure was possible."

Steffensen's research suggests that the process of a brain becoming addicted is similar to a driver overcorrecting a vehicle. When drugs and alcohol release unnaturally high levels of dopamine in the brain's pleasure system, oxidative stress occurs in the brain.

Steffensen and his collaborators have found that the brain responds by generating a protein called BDNF (brain derived neurotrophic factor). This correction suppresses the brain's normal production of dopamine long after someone comes down from a high. Not having enough dopamine is what causes the pains, distress and anxiety of withdrawal.

"The body attempts to compensate for unnatural levels of dopamine, but a pathological process occurs," Steffensen said. "We think it all centers around a subset of neurons that ordinarily put the brakes on dopamine release."

A group of undergraduate students work in Steffensen's lab along with post-doctoral fellows and graduate students. Jennifer Blanchard Mabey, a graduate student in neuroscience, co-authored a paper about withdrawal that is in the current issue of the Journal of Neuroscience.

"It's rewarding to see that your research efforts place another small piece in the enormous addiction puzzle," said Mabey.

A separate study, co-authored by Steffensen and Ph.D. candidates Nathan Schilaty and David Hedges, explains how nicotine and alcohol interact in the brain.

"Addiction is a huge concern in our society and is very misunderstood," Schilaty said. "Our research is helping us to formulate ideas on how we can better help these individuals through non-invasive and non-pharmacological means."

Eun Young Jang, a post-doctoral fellow in Steffensen's lab, authored a third paper for Addiction Biology describing the effects of cocaine addiction on the brain's reward circuitry.

In these three research papers, dopamine is the common thread.

"I am optimistic that in the near future medical science will be able to reverse the brain changes in dopamine transmission that occur with drug dependence and return an 'addict' to a relatively normal state," Steffensen said. "Then the addict will be in a better position to make rational decisions regarding their behavior and will be empowered to remain drug free."


'/>"/>

Contact: Joe Hadfield
joe_hadfield@byu.edu
801-422-9206
Brigham Young University
Source:Eurekalert

Related medicine news :

1. Studies: Current hepatitis C treatments cant be used by more than half of patients; others lose opportunity for treatment
2. Studies: Motor control development continues longer than previously believed
3. The biology of addiction risk looks like addiction
4. Cocaine addiction: Phase-specific biology and treatment?
5. Does food addiction exist?
6. Researchers recast addiction as a manageable disease
7. Opioid overdose prevention programs may reduce deaths, reports Journal of Addiction Medicine
8. Most emergency department super-frequent users have a substance abuse addiction
9. Study of third hand nicotine from e-cigarette exposure wins NIH Addiction Science Award
10. Researchers ID changes that may occur in neural circuits due to cocaine addiction
11. Mount Sinai researchers identify changes that may occur in neural circuits due to addiction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in healthcare events ... Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the ... The annual award competition recognizes editorial and design excellence across a range of sectors. ...
(Date:10/12/2017)... Wesley Chapel, FL (PRWEB) , ... October 12, 2017 , ... ... Chapel is holding a treadmill relay – Miles by Moonlight to raise money for ... by donating $300 or more. , Teams will work together to keep their ...
(Date:10/12/2017)... ... , ... Health Literacy Innovations (HLI), creator of the Health ... Cancer Patient Education Network (CPEN), an independent professional organization that shares best practices ... , As CPEN’s strategic partner, HLI will help support CPEN members by ...
(Date:10/12/2017)... Miramar, FL (PRWEB) , ... October 12, 2017 ... ... is presenting the latest in wound care advancements to physician colleagues, skilled nursing ... lecture is titled, "Navigating the Treacherous Waters of Wound Care." , "At many ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Lilly and Company (NYSE: LLY ) will ... 2017 on Tuesday, October 24, 2017. Lilly will also ... investment community and media to further detail the company,s ... at 9 a.m. Eastern time. Investors, media and the ... conference call through a link that will be posted ...
(Date:9/28/2017)... , Sept. 28, 2017 Cohen Veterans ... advance the use of wearable and home sensors for ... disorders. Early Signal Foundation, a nonprofit organization focused on ... will provide an affordable analytical system to record and ... ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
Breaking Medicine Technology: